These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 31638931

  • 1. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
    Abdi J, Rastgoo N, Chen Y, Chen GA, Chang H.
    BMC Cancer; 2019 Oct 21; 19(1):975. PubMed ID: 31638931
    [Abstract] [Full Text] [Related]

  • 2. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.
    Yuan X, Ma R, Yang S, Jiang L, Wang Z, Zhu Z, Li H.
    Cell Cycle; 2019 Jul 21; 18(14):1660-1669. PubMed ID: 31204563
    [Abstract] [Full Text] [Related]

  • 3. Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.
    Zhang H, Du Z, Tu C, Zhou X, Menu E, Wang J.
    Cancer Res; 2024 Jan 02; 84(1):39-55. PubMed ID: 37756570
    [Abstract] [Full Text] [Related]

  • 4. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
    Lyu H, Wang S, Huang J, Wang B, He Z, Liu B.
    Cancer Lett; 2018 Apr 28; 420():97-108. PubMed ID: 29409974
    [Abstract] [Full Text] [Related]

  • 5. CircRNA ITCH increases bortezomib sensitivity through regulating the miR-615-3p/PRKCD axis in multiple myeloma.
    Liu J, Du F, Chen C, Li D, Chen Y, Xiao X, Hou X.
    Life Sci; 2020 Dec 01; 262():118506. PubMed ID: 33031827
    [Abstract] [Full Text] [Related]

  • 6. Circular RNA circ-CCT3 promotes bortezomib resistance in multiple myeloma via modulating miR-223-3p/BRD4 axis.
    Liu D, Wang Y, Li H, Peng S, Tan H, Huang Z.
    Anticancer Drugs; 2022 Jan 01; 33(1):e145-e154. PubMed ID: 34387610
    [Abstract] [Full Text] [Related]

  • 7. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Xu K, Yagüe E.
    Breast Cancer Res Treat; 2015 Jun 01; 151(2):269-80. PubMed ID: 25900794
    [Abstract] [Full Text] [Related]

  • 8. Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells.
    Che F, Ye X, Wang Y, Ma S, Wang X.
    Eur J Pharmacol; 2021 Jan 15; 891():173752. PubMed ID: 33253679
    [Abstract] [Full Text] [Related]

  • 9. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p.
    Pan Y, Zhang Y, Liu W, Huang Y, Shen X, Jing R, Pu J, Wang X, Ju S, Cong H, Chen H.
    Cell Death Dis; 2019 Feb 06; 10(2):106. PubMed ID: 30728351
    [Abstract] [Full Text] [Related]

  • 10. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
    Leotta M, Biamonte L, Raimondi L, Ronchetti D, Di Martino MT, Botta C, Leone E, Pitari MR, Neri A, Giordano A, Tagliaferri P, Tassone P, Amodio N.
    J Cell Physiol; 2014 Dec 06; 229(12):2106-16. PubMed ID: 24819167
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
    Pitari MR, Rossi M, Amodio N, Botta C, Morelli E, Federico C, Gullà A, Caracciolo D, Di Martino MT, Arbitrio M, Giordano A, Tagliaferri P, Tassone P.
    Oncotarget; 2015 Sep 29; 6(29):27343-58. PubMed ID: 26160841
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA, Desantis V, Di Marzo L, Craparotta I, Beltrame L, Marchini S, Annese T, Visino F, Arciuli M, Saltarella I, Lamanuzzi A, Solimando AG, Nico B, De Angelis M, Racanelli V, Mariggiò MA, Chiacchio R, Pizzuti M, Gallone A, Fumarulo R, D'Incalci M, Vacca A.
    J Pathol; 2019 Feb 29; 247(2):241-253. PubMed ID: 30357841
    [Abstract] [Full Text] [Related]

  • 13. Effect miR-214-3p on proliferation and apoptosis of breast cancer cells by targeting survivin protein.
    Han LC, Wang H, Niu FL, Yan JY, Cai HF.
    Eur Rev Med Pharmacol Sci; 2019 Sep 29; 23(17):7469-7474. PubMed ID: 31539134
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.
    Huang J, Huang LQ, He HS, Yan J, Huang C, Wang R, Guan Y, Huang DP.
    Life Sci; 2020 Sep 15; 257():118088. PubMed ID: 32663573
    [Abstract] [Full Text] [Related]

  • 15. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation.
    Wang X, Li C, Ju S, Wang Y, Wang H, Zhong R.
    Leuk Lymphoma; 2011 Oct 15; 52(10):1991-8. PubMed ID: 21718132
    [Abstract] [Full Text] [Related]

  • 16. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
    Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z, Jiang M, Chen M, Wang X, Kang Y, Zhou Y, Ni Chonghaile T, Johncilla ME, Tai YT, Cheng JQ, Letai A, Munshi NC, Anderson KC, Carrasco RD.
    Cancer Res; 2015 Oct 15; 75(20):4384-4397. PubMed ID: 26249174
    [Abstract] [Full Text] [Related]

  • 17. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
    Yang B, Huang J, Liu H, Guo W, Li G.
    Tumour Biol; 2016 Feb 15; 37(2):1771-9. PubMed ID: 26318298
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2.
    Tian F, Zhan Y, Zhu W, Li J, Tang M, Chen X, Jiang J.
    Int J Mol Med; 2019 Feb 15; 43(2):1058-1066. PubMed ID: 30535471
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
    Phatak P, Byrnes KA, Mansour D, Liu L, Cao S, Li R, Rao JN, Turner DJ, Wang JY, Donahue JM.
    Oncogene; 2016 Apr 21; 35(16):2087-97. PubMed ID: 26234674
    [Abstract] [Full Text] [Related]

  • 20. MiR-197-3p reduces bortezomib resistance in multiple myeloma by inhibiting IL-6 expression in a MEAF6-dependent manner.
    Liu Y, Cheng P, Zhao W, Zhu L, Sui J, Dai Y, Lai Y.
    Leuk Res; 2022 Mar 21; 114():106785. PubMed ID: 35074616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.